Efficacy and Safety of Low- and High-Dose Cariprazine in Acute and Mixed Mania Associated With Bipolar I Disorder: A Double-Blind, Placebo-Controlled Study

狂躁 双相情感障碍 情感障碍症 精神科 心理学 医学 临床心理学 心情
作者
Joseph R. Calabrese,Paul E. Keck,Anju Starace,Kaifeng Lu,Adam Ruth,I. Laszlovszky,György Németh,Suresh Durgam
出处
期刊:The Journal of Clinical Psychiatry [Physicians Postgraduate Press, Inc.]
卷期号:76 (03): 284-292 被引量:124
标识
DOI:10.4088/jcp.14m09081
摘要

OBJECTIVE: This phase 3 trial evaluated the efficacy, safety, and tolerability of low- and high-dose cariprazine in patients meeting DSM-IV-TR criteria for acute manic or mixed episodes associated with bipolar I disorder. METHOD: This multicenter, randomized, double-blind, placebo-controlled, parallel-group, fixed/flexible-dose study was conducted from February 2010 to December 2011. Patients were randomly assigned to placebo, cariprazine 3-6 mg/d, or cariprazine 6-12 mg/d for 3 weeks of double-blind treatment. Primary and secondary efficacy parameters were change from baseline to week 3 in Young Mania Rating Scale (YMRS) total score and Clinical Global Impressions-Severity of Illness (CGI-S) score, respectively. Post hoc analysis examined change from baseline to week 3 in YMRS single items. RESULTS: A total of 497 patients were randomized; 74% completed the study. The least squares mean difference (LSMD) for change from baseline to week 3 in YMRS total score was statistically significant in favor of both cariprazine groups versus placebo (LSMD [95% CI]: 3-6 mg/d, -6.1 [-8.4 to -3.8]; 6-12 mg/d, -5.9 [-8.2, -3.6]; P < .001 [both]). Both cariprazine treatment groups showed statistically significant superiority to placebo on all 11 YMRS single items (all comparisons, P < .05). Change from baseline in CGI-S scores was statistically significantly greater in both cariprazine groups compared with placebo (LSMD [95% CI]: 3-6 mg/d, -0.6 [-0.9 to -0.4]; 6-12 mg/d, -0.6 [-0.9 to -0.3]; P < .001 [both]). The most common (≥ 5% and twice the rate of placebo) treatment-related adverse events for cariprazine were akathisia (both groups) and nausea, constipation, and tremor (6-12 mg/d only). CONCLUSIONS: Results of this study demonstrated that both low- and high-dose cariprazine were more effective than placebo in the treatment of acute manic or mixed episodes associated with bipolar I disorder. Cariprazine was generally well tolerated, although the incidence of akathisia was greater with cariprazine than with placebo. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT01058668.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
辣椒完成签到,获得积分10
刚刚
无极微光的应助被邓111111采纳,获得20
刚刚
啵子发布了新的文献求助10
1秒前
李爱国的应助被Z20251040501采纳,获得10
1秒前
1秒前
wanci的应助被太空的脚步采纳,获得10
1秒前
1秒前
YoPbsn发布了新的文献求助10
2秒前
蟑螂恶霸完成签到,获得积分10
2秒前
2秒前
4秒前
6秒前
852的应助被饺子采纳,获得10
6秒前
明亮曼易发布了新的文献求助10
6秒前
7秒前
顺顺完成签到,获得积分10
7秒前
樊振东完成签到 ,获得积分10
7秒前
7秒前
斯文曼波发布了新的文献求助10
8秒前
呼呼完成签到,获得积分10
9秒前
研友_ngqgY8完成签到,获得积分10
9秒前
qqq完成签到 ,获得积分10
9秒前
爆米花的应助被辛勤的振家采纳,获得10
10秒前
天天向上的应助被123采纳,获得10
10秒前
风吹麦浪的应助被轻松念之采纳,获得10
10秒前
鹅鹅鹅完成签到,获得积分10
10秒前
11秒前
11秒前
yyyyy发布了新的文献求助10
12秒前
SciGPT的应助被冷傲新柔采纳,获得10
12秒前
呼呼发布了新的文献求助10
12秒前
12秒前
12秒前
13秒前
13秒前
langzi完成签到,获得积分10
13秒前
14秒前
似水流年发布了新的文献求助10
14秒前
SciGPT的应助被五号采纳,获得10
15秒前
Seorina的应助被AlexMoser采纳,获得10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187918
求助须知:如何正确求助?哪些是违规求助? 9575850
关于积分的说明 21843829
捐赠科研通 7785760
什么是DOI,文献DOI怎么找? 3435128
关于科研通互助平台的介绍 2559501
邀请新用户注册赠送积分活动 2482027